Clinical trial Recruiting at 1 site Interventional Ages 20 and up

fNIRS study of brain activity during robot-assisted hand therapy after stroke

Official title: Functional Near-infrared Spectroscopy (fNIRS) is an Ideal Tool to Monitor Cortical Brain Activity and Understand the Mechanism Underlying Recovery Following Stroke

Run by Chang Gung Memorial Hospital · NCT07623512 · Data updated 2026-11-12

This study tests how brain activity changes during end-effector and exoskeleton robot-assisted hand movements in people who had a stroke, to see if therapy supports motor recovery.

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment108 (estimated)
SponsorChang Gung Memorial Hospital
Academic / other
Locations1 site (Taoyuan)
StatusRecruiting
StartedNovember 28, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedJune 16, 2026
Trial IDNCT07623512 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with unilateral stroke at least 3 months prior and meeting FMA-UE 18–56, with manageable spasticity and adequate instruction-following ability.

Probably not a fit

Patients with uncontrolled medical conditions, severe spasticity, orthopedic or other neurological issues affecting the arm, or recent Botulinum toxin treatment may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study uses functional near-infrared spectroscopy (fNIRS) to observe brain activation during two types of robot-assisted hand movements. Part 1 compares brain patterns in healthy adults and stroke patients in a cross-sectional session with each robot type. Part 2 uses an evaluator-blinded randomized design to examine longitudinal changes in brain activity and motor recovery over six weeks, with participants stratified by impairment and lesion side. Interventions include robotic hand therapy (EE or Exo) and functional training, conducted at Chang Gung Memorial Hospital.

Why it matters

Potential benefit: If successful, the approach could improve understanding of how robot-assisted hand therapy influences brain reorganization and motor recovery after stroke.

How similar studies have gone: Previous work suggests functional brain changes can accompany robot-assisted motor training, but this study adds longitudinal fNIRS data in stroke patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Stroke participants

Inclusion Criteria:

* unilateral stroke onset ≥ 3 months
* Fugl-Meyer Assessment for Upper Extremity (FMA-UE) score between 18 to 56 - modified Ashworth scale ≤ 3 in proximal joints and modified Ashworth scale ≤ 2 in distal joints
* able to follow 2-step instructions
* without excessive spasticity in any of the UE joints.

Exclusion Criteria:

* orthopedic conditions affecting the arm/hand or other neurological conditions
* severe pain that prevents movement in the affected arm and hand
* implanted cardiac pacemakers and cardioverter-defibrillators
* osteoporosis, fracture, or severe ataxia
* unstable medical status
* participating in other rehabilitation or drug studies simultaneously
* receiving Botulinum toxin injections within 3 months

Healthy participants

* have no neurological conditions
* have no musculoskeletal disorders affecting the UE

Where it's running

  • Chang Gung Memorial Hospital
    Taoyuan, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.